Oxford Nanopore Technologies
Oxford Nanopore has developed a new generation of DNA/RNA sequencing technology. It is the only sequencing technology that offers real-time analysis in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths.
Latest Content
Product News
Cepheid and Oxford Nanopore Technologies Partner To Advance Automated Sequencing-Based Solutions
Oxford Nanopore and Cepheid to co-develop a rapid sequencing workflow for in-house infectious disease diagnostics.
Industry Insight
European Consortium Will Advance Long-Read Sequencing in Clinics
A new pan-European network will integrate long-read sequencing into clinical practice, improving diagnosis of rare diseases and cancers.
Webinar
Integrating Nanopore Sequencing Into Clinical Research: Case Studies in Pathogen, Cancer and Genomics Analysis
In this webinar, Dr. Alfredo Hildalgo Miranda will demonstrate the potential and flexibility of Oxford Nanopore Technologies’ sequencing platforms in cancer and infectious disease research.
Product News
Oxford Nanopore Expands Compatibility With 10x Genomics To Unlock Deeper Insights in Single-Cell Transcriptomics
Oxford Nanopore Technologies announced its expanded collaboration with 10x Genomics, Inc. to enable seamless compatibility between their latest technologies.
Product News
Oxford Nanopore and UK Biobank To Create World’s First Epigenetic Dataset Targeting the Causes of Cancer, Dementia, Complex Disease
Oxford Nanopore Technologies, announced a new collaboration with UK Biobank to create the world’s first comprehensive, large-scale epigenetic dataset.
Webinar
Delivering the Future of Microbial Genomics With Direct and Real-Time Sequencing
On-Demand
Explore how nanopore sequencing is revolutionizing microbial genomics! Join Richard Chalvignac as he covers NO-MISS workflows, avian flu surveillance, 16S/ITS sequencing, and more. Live Q&A included. Don’t miss this exciting webinar!
Product News
Oxford Nanopore Announces Landmark UK Government Partnership To Advance Genomics-Driven Healthcare Innovation in the UK
Oxford Nanopore, announced a landmark strategic partnership with the UK Government. This partnership brings together the UK’s world-class scientific organisations Genomics England, UK Biobank and NHS England, alongside Oxford Nanopore.
Webinar
Unlocking Genomic Insights: Real-Time Sequencing With Pocket Size Devices
On-Demand
For researchers in the field – from Alaska to the International Space Station – a real-time portable sequencer can lower the barrier to accessing genomic information, bringing new insights into organisms by sequencing directly in extreme environments
Product News
Breakthrough Towards Protein Sequencing Using Oxford Nanopore Holds Promise for Disease Research and Drug Development
New protein sequencing ‘proof-of-concept' method published in Nature shows promise in sequencing long, intact protein strands at single molecule resolution.
Webinar
Exploring the Potential of Nanopore Sequencing in Transforming Cancer Care
On-Demand
Technological advances in molecular biology have revolutionized the management of cancer patients, and also assisted their relatives in cases of genetic predisposition identification.
Advertisement
